About
Charlie Johnson Prior to joining ADC Biotechnology as Commercial Director in early 2012, Johnson was Director for the High Potency Division of Dishman group's Carbogen Amcis operation, headquartered in Basel. Until January 2009, he served as Business Manager for the strategic marketing of the oncology portfolio of Italy's UQUIFA. From 2002 – 2007 he was Commercial Manager for Avecia Pharmaceuticals' (later Piramal's) High Potency Actives business. He co-founded Avecia's dedicated ADC operations in Grangemouth in 2004, when the segment was in its infancy. He previously held a series of pharma-related roles with ICI and Astra Zeneca. Charlie graduated with a BSc Hons. in Applied Chemistry from Liverpool John Moores University.
Investment Focus
- Location
- Newland, UK
Contact Information
Find more investors like Charlie
Search Investors